155 related articles for article (PubMed ID: 38266130)
1. Disturbed atrial metabolism, shear stress, and cardiac load contribute to atrial fibrillation after ablation: AXAFA biomolecule study.
Chua W; Khashaba A; Canagarajah H; Nielsen JC; di Biase L; Haeusler KG; Hindricks G; Mont L; Piccini J; Schnabel RB; Schotten U; Wienhues-Thelen UH; Zeller T; Fabritz L; Kirchhof P
Europace; 2024 Feb; 26(2):. PubMed ID: 38266130
[TBL] [Abstract][Full Text] [Related]
2. Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation.
Staszewsky L; Meessen JMTA; Novelli D; Wienhues-Thelen UH; Disertori M; Maggioni AP; Masson S; Tognoni G; Franzosi MG; Lucci D; Latini R
BMC Cardiovasc Disord; 2021 Nov; 21(1):553. PubMed ID: 34798808
[TBL] [Abstract][Full Text] [Related]
3. Bone Morphogenetic Protein 10-A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation.
Hennings E; Blum S; Aeschbacher S; Coslovsky M; Knecht S; Eken C; Lischer M; Paladini RE; Krisai P; Reichlin T; Rodondi N; Beer JH; Ammann P; Conte G; De Perna ML; Kobza R; Blum MR; Bossard M; Kastner P; Ziegler A; Müller C; Bonati LH; Pfister O; Zuern CS; Conen D; Kühne M; Osswald S;
J Am Heart Assoc; 2023 Mar; 12(6):e028255. PubMed ID: 36926939
[TBL] [Abstract][Full Text] [Related]
4. Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation.
Reyat JS; Chua W; Cardoso VR; Witten A; Kastner PM; Kabir SN; Sinner MF; Wesselink R; Holmes AP; Pavlovic D; Stoll M; Kääb S; Gkoutos GV; de Groot JR; Kirchhof P; Fabritz L
JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32814717
[TBL] [Abstract][Full Text] [Related]
5. Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation.
Giannopoulos G; Kossyvakis C; Angelidis C; Efremidis M; Panagopoulou V; Letsas K; Bouras G; Vassilikos VP; Goudevenos J; Tousoulis D; Lekakis J; Deftereos S
Heart Rhythm; 2015 Jul; 12(7):1470-5. PubMed ID: 25847478
[TBL] [Abstract][Full Text] [Related]
6. Association between left atrial appendage emptying velocity, N-terminal plasma brain natriuretic peptide levels, and recurrence of atrial fibrillation after catheter ablation.
Ma XX; Zhang YL; Hu B; Jiang WJ; Wang M; Zheng DY; Zhu MR; Xue XP
J Interv Card Electrophysiol; 2017 Apr; 48(3):343-350. PubMed ID: 27943042
[TBL] [Abstract][Full Text] [Related]
7. Association of bone morphogenetic protein 10 and recurrent atrial fibrillation after catheter ablation.
Hennings E; Aeschbacher S; Coslovsky M; Paladini RE; Meyre PB; Voellmin G; Blum L; Kastner P; Ziegler A; Conen D; Zuern CS; Krisai P; Badertscher P; Sticherling C; Osswald S; Knecht S; Kühne M
Europace; 2023 Jun; 25(6):. PubMed ID: 37314197
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation.
Hijazi Z; Benz AP; Lindbäck J; Alexander JH; Connolly SJ; Eikelboom JW; Granger CB; Kastner P; Lopes RD; Ziegler A; Oldgren J; Siegbahn A; Wallentin L
Eur Heart J; 2023 Jan; 44(3):208-218. PubMed ID: 36380569
[TBL] [Abstract][Full Text] [Related]
9. NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation.
Fan J; Cao H; Su L; Ling Z; Liu Z; Lan X; Xu Y; Chen W; Yin Y
J Interv Card Electrophysiol; 2012 Jan; 33(1):93-100. PubMed ID: 21938519
[TBL] [Abstract][Full Text] [Related]
10. An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditions.
Chua W; Cardoso VR; Guasch E; Sinner MF; Al-Taie C; Brady P; Casadei B; Crijns HJGM; Dudink EAMP; Hatem SN; Kääb S; Kastner P; Mont L; Nehaj F; Purmah Y; Reyat JS; Schotten U; Sommerfeld LC; Zeemering S; Ziegler A; Gkoutos GV; Kirchhof P; Fabritz L
Sci Rep; 2023 Oct; 13(1):16743. PubMed ID: 37798357
[TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
[TBL] [Abstract][Full Text] [Related]
12. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.
Büttner P; Schumacher K; Dinov B; Zeynalova S; Sommer P; Bollmann A; Husser D; Hindricks G; Kornej J
Heart Rhythm; 2018 Aug; 15(8):1132-1137. PubMed ID: 29604419
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers and arrhythmia recurrence following radiofrequency ablation of atrial fibrillation.
Carballo D; Noble S; Carballo S; Stirnemann J; Muller H; Burri H; Vuilleumier N; Talajic M; Tardif JC; Keller PF; Mach F; Shah D
J Int Med Res; 2018 Dec; 46(12):5183-5194. PubMed ID: 30178684
[TBL] [Abstract][Full Text] [Related]
14. Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study.
Xiao J; Persson AP; Engström G; Johnson LSB
BMC Cardiovasc Disord; 2021 Mar; 21(1):134. PubMed ID: 33711943
[TBL] [Abstract][Full Text] [Related]
15. Atrial ectopy and N-terminal pro-B-type natriuretic peptide as predictors of atrial fibrillation: a population-based cohort study.
Kumarathurai P; Mouridsen MR; Mattsson N; Larsen BS; Nielsen OW; Gerds TA; Sajadieh A
Europace; 2017 Mar; 19(3):364-370. PubMed ID: 27194537
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers associated with rhythm status after cardioversion in patients with atrial fibrillation.
Meyre PB; Aeschbacher S; Blum S; Voellmin G; Kastner PM; Hennings E; Kaufmann BA; Kühne M; Osswald S; Conen D
Sci Rep; 2022 Jan; 12(1):1680. PubMed ID: 35102265
[TBL] [Abstract][Full Text] [Related]
17. Increased NT-pro-B-type natriuretic peptide independently predicts outcome following catheter ablation of atrial fibrillation.
Nilsson B; Goetze JP; Chen X; Pehrson S; Svendsen JH
Scand J Clin Lab Invest; 2009; 69(8):843-50. PubMed ID: 19929271
[TBL] [Abstract][Full Text] [Related]
18. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
[TBL] [Abstract][Full Text] [Related]
20. The association between alcohol consumption, cardiac biomarkers, left atrial size and re-ablation in patients with atrial fibrillation referred for catheter ablation.
Barmano N; Charitakis E; Kronstrand R; Walfridsson U; Karlsson JE; Walfridsson H; Nystrom FH
PLoS One; 2019; 14(4):e0215121. PubMed ID: 30970005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
